The Oligonucleotide Synthesis Market size was estimated at USD 7.8 billion in 2022 and is expected to reach USD 27.5 billion by 2030 at a CAGR of 17.1% during the forecast period of 2023-2030.
Oligonucleotides are fragments of nucleic acids generated through enzymatic chemistry and genetic engineering. Oligonucleotides are mostly used in research facilities for diagnostic, academic & industrial applications and therapeutic purposes. Oligonucleotide synthesis occurs either commercially to give capabilities to multiple end-users or individually through DNA synthesizers for self-utilization.
.png)
Get more information on Oligonucleotide Synthesis Market - Request Free Sample Report
The advanced synthesis of oligonucleotides yields longer oligos with increased sequence fidelity and purity, which can be used in a variety of molecular biology applications. Various pharmaceutical and biotechnology businesses are always working on developing newer and more effective synthetic chemistry processes. For example, Integrated DNA Technologies, a leader in synthetic oligonucleotides, has pioneered several methods for synthesizing oligonucleotides of extreme lengths. The business has created oligonucleotides with lengths of up to 201 bases that are employed in the production of mini-genes using mass spectrometry.
DRIVERS
Government Fundraising Initiatives
There are increasing government initiatives to raise financing for various genome projects in order to produce new therapies for a variety of chronic and rare diseases. This is likely to boost the market growth by increasing demand for oligonucleotides used in medication development.
RESTRAIN
microarray-generated oligonucleotide of poor quality
Natural oligonucleotides have a base of ribose or deoxyribose sugar phosphate, which is rapidly destroyed in the body by the nucleus. Moreover, in generic testing, oligo-degradation can impact cell growth and proliferation. Furthermore, the low quality of oligonucleotide sequences created by microarrays is a major barrier to using microarray Type for oligonucleotide synthesis. These reasons are projected to restrain the expansion of the worldwide oligonucleotide synthesis market.
OPPORTUNITY
Rising adoption of oligonucleotides in Molecular Diagnostics
increasing adoption of clinical applications contribute to market growth.
Growing focus on personalized medicine
The growing focus on customized treatment is expected to positively impact the growth of the oligonucleotide synthesis market during the projected period. Personalized medicine provides patients with medical treatment that is personalized to their own requirements and choices. Oligonucleotide synthesis aids in the provision of individualized solutions to sick patients. The introduction of anti-sense RNA therapeutics has generated significant interest in the biotype sector. With oligonucleotide synthesis, the potential application of tailored therapy to treat rare disorders is possible. Patients can be treated and diagnosed more effectively as oligonucleotide synthesis advances. As a result, the increased emphasis on individualized treatment is projected to provide several opportunities for industry participants.
CHALLENGES
Cost erosion of synthesized oligos
The cost erosion of synthesized oligos, as well as the lack of a consistent set of criteria for therapeutic oligos, are expected to limit the growth of the oligonucleotide synthesis market during the forecast period.
The Russian invasion of Ukraine has a significant influence on the country's universities and research organizations. This column uses freshly created data to show an 11% drop in research articles published by Ukrainian scientists since the war began. This is mostly due to disruptions in human capital and decreased international cooperation, rather than damaged physical capital. To effectively protect Ukraine's scientific future, policy should prioritize reducing shocks to human capital.
The Russian-Ukraine war has a negative impact on human capital, which includes scientists undertaking research at universities and laboratories. Many scientists have been compelled to quit their residences and relocate to other parts of Ukraine or elsewhere in the world. Others have joined the army to fight or have been slain directly in the battle. Second, physical capital may have been harmed as a result of the war, as schools, labs, and other vital buildings were damaged or destroyed. Third, the war has hampered the exchange of scientific knowledge and ideas by making it more difficult for researchers to attend conferences, seminars, and travel to collaborate with co-authors.
IMPACT OF ONGOING RECESSION
According to Goldman Sachs analysts, the diagnostic sector faces a "challenging set-up" in 2022 as economic slowdowns in the United States and Europe undercut chances for a post-pandemic volume recovery. Analysts predicted that there will be "limited visibility over the course of the year" as corporations report second-quarter results, and that businesses may need to focus more on demonstrating their paths to profitability in a more tough macro environment. Investor attitude shifts, along with the possibility of a recession, may make it more difficult for businesses to acquire finance, according to Goldman Sachs. According to the experts, Invitae has a "tighter cash picture."
By Product
Oligonucleotides
Oligonucleotides, By Product Type
Column-based Oligos
Array-based Oligos
Oligonucleotides, By Nucleic Acid Type
DNA
RNA
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
25 nmol
50 nmol
200 nmol
1000 nmol
10,000 nmol
Purification
Modification
In 2022, Services segment is expected to held the highest market share of 30.1% during the forecast period due to certain factors, such as the increasing usage of molecular diagnostic tests and the increased adoption of oligonucleotide therapies, are projected to drive the market expansion. Furthermore, significant businesses are diversifying their offers by entering new markets or acquiring service providers in different nations.
By Type
Custom
Predesigned
By Application
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications
In 2022, the PCR Primers segment is expected to dominate the market growth of 23.5% during the forecast period. Primers are the most commonly utilized oligonucleotide in PCR. They are part of complementary sequences to the 5' end of the targeted sequence and are utilized for sequencing or amplification. Primers are increasingly being used in gene sequencing investigations. Because of their usage in fluorescence detection and target amplification, several primer designs with diverse probe- and primer-based detection chemistries have been developed. With technological advancements, PCR has evolved into RT-PCR, qPCR, and digital PCR. PCR assays and panels are used to detect and quantify gene expression. The demand for primers to meet the application of these upgraded systems, such as accurate quantification of gene expression, is expected to drive market expansion.
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-BioType Companies
.png)
Need any customization research on Oligonucleotide Synthesis Market - Enquiry Now
In 2022, the Academic Research Institutes segment is expected to dominate the market growth of 43.0% during the forecast period owing to the considerable genomic research being conducted by universities and academic research centers, either in partnership with private investors or with government funding. Massive investment in genetic research by industrialized countries in order to compete and lead the global market has provided financial support to academic research.
North America held a significant market share growing with a CAGR of 32.4% in 2022 due to the large number of corporations and research institutes that are creating a strong demand for oligonucleotides. For example, in April 2022, DNAScript teamed with Moderna and received a USD 5.1 million award from the US Defense Advanced Research Projects Agency. As part of the worldwide nucleic acids on-demand effort, this collaboration aimed to create a prototype for robust therapeutic and vaccine manufacturing.
Asia-Pacific is witnessing to expand fastest CAGR rate of 15.0% during the forecast period. This is because important players in emerging markets are growing interest in increasing their profits. To increase their revenue creation and achieve a larger market share, players have used various techniques such as acquisitions, collaborations, and distribution agreements.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Thermo Fisher Scientific, Inc., CPI, Novartis, AstraZeneca, Merck & Co., Inc., GE Healthcare, Dharmacon Inc., Agilent Technologies, Bio-synthesis, Kaneka Eurogentec S.A, Integrated DNA Technologies, Inc., BioAutomation, Biolegio, Twist Bioscience, SpeeDx and Others.
CPI, Novartis, AstraZeneca, and the University of Manchester, in February 2023, CPI, Novartis, AstraZeneca, and the University of Manchester formed a collaboration to increase patient access to potentially life-saving oligonucleotide therapies. This collaboration aims to transform the use of oligonucleotide-based medicines in the treatment of various life-threatening disorders.
SpeeDx, in September 2021, SpeeDx will invest in local oligonucleotide production to reduce supply chain risk and establish a more critical sovereign capacity for important diagnostics. Such innovations are projected to expand the use of oligonucleotides in medication development, fueling market growth during the forecast period.
| Report Attributes | Details |
| Market Size in 2022 | US$ 7.8 Billion |
| Market Size by 2030 | US$ 27.5 Billion |
| CAGR | CAGR of 17.1% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Oligonucleotides, Equipment/Synthesizer, Reagents, Services, Purification, Modification) • By Type (Custom, Predesigned) • By Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, FISH, Antisense Oligonucleotides, Other Applications) • By End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical-BioType Companies) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., CPI, Novartis, AstraZeneca, Merck & Co., Inc., GE Healthcare, Dharmacon Inc., Agilent Technologies, Bio-synthesis, Kaneka Eurogentec S.A, Integrated DNA Technologies, Inc., BioAutomation, Biolegio, Twist Bioscience, SpeeDx |
| Key Drivers | • Government Fundraising Initiatives |
| Market Challenges | • Cost erosion of synthesized oligos |
Ans: The Oligonucleotide Synthesis Market size was valued at US$ 7.8 billion in 2022 and is expected to reach USD 7.8 billion in 2022.
Ans: The Oligonucleotide Synthesis Market is expected to grow at 17.1% CAGR from 2023 to 2030.
Ans: Oligonucleotide Synthesis Market size was valued at USD 7.8 billion in 2022.
Ans: Rising demand for Covid-19 diagnostics and increasing government initiatives.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Oligonucleotide Synthesis Market Segmentation, by Product
8.1 Oligonucleotides
8.1.1 Oligonucleotides, By Product Type
8.1.1.1 Column-based Oligos
8.1.1.2 Array-based Oligos
8.1.2 Oligonucleotides, By Nucleic Acid Type
8.1.2.1 DNA
8.1.2.2 RNA
8.2 Equipment/Synthesizer
8.3 Reagents
8.4 Services
8.4.1 Oligo Synthesis
8.4.1.1 25 nmol
8.4.1.2 50 nmol
8.4.1.3 200 nmol
8.4.1.4 1000 nmol
8.4.1.5 10,000 nmol
8.5 Purification
8.6 Modification
9. Oligonucleotide Synthesis Market Segmentation, by Type
9.1 Custom
9.2 Predesigned
10. Oligonucleotide Synthesis Market Segmentation, by Application
10.1 PCR Primers
10.2 PCR Assays and Panels
10.3 Sequencing
10.4 DNA Microarrays
10.5 Fluorescence In Situ Hybridization (FISH)
10.6 Antisense Oligonucleotides
10.7 Other Applications
11. Oligonucleotide Synthesis Market Segmentation, by End User
11.1 Academic Research Institutes
11.2 Diagnostic Laboratories
11.3 Pharmaceutical-BioType Companies
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Oligonucleotide Synthesis Market by Country
12.2.2 North America Oligonucleotide Synthesis Market by Product
12.2.3 North America Oligonucleotide Synthesis Market by Type
12.2.4 North America Oligonucleotide Synthesis Market by Application
12.2.5 North America Oligonucleotide Synthesis Market by End User
12.2.6 USA
12.2.6.1 USA Oligonucleotide Synthesis Market by Product
12.2.6.2 USA Oligonucleotide Synthesis Market by Type
12.2.6.3 USA Oligonucleotide Synthesis Market by Application
12.2.6.4 USA Oligonucleotide Synthesis Market by End User
12.2.7 Canada
12.2.7.1 Canada Oligonucleotide Synthesis Market by Product
12.2.7.2 Canada Oligonucleotide Synthesis Market by Type
12.2.7.3 Canada Oligonucleotide Synthesis Market by Application
12.2.7.4 Canada Oligonucleotide Synthesis Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Oligonucleotide Synthesis Market by Product
12.2.8.2 Mexico Oligonucleotide Synthesis Market by Type
12.2.8.3 Mexico Oligonucleotide Synthesis Market by Application
12.2.8.4 Mexico Oligonucleotide Synthesis Market by End User
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Eastern Europe Oligonucleotide Synthesis Market by Country
12.3.1.2 Eastern Europe Oligonucleotide Synthesis Market by Product
12.3.1.3 Eastern Europe Oligonucleotide Synthesis Market by Type
12.3.1.4 Eastern Europe Oligonucleotide Synthesis Market by Application
12.3.1.5 Eastern Europe Oligonucleotide Synthesis Market by End User
12.3.1.6 Poland
12.3.1.6.1 Poland Oligonucleotide Synthesis Market by Product
12.3.1.6.2 Poland Oligonucleotide Synthesis Market by Type
12.3.1.6.3 Poland Oligonucleotide Synthesis Market by Application
12.3.1.6.4 Poland Oligonucleotide Synthesis Market by End User
12.3.1.7 Romania
12.3.1.7.1 Romania Oligonucleotide Synthesis Market by Product
12.3.1.7.2 Romania Oligonucleotide Synthesis Market by Type
12.3.1.7.3 Romania Oligonucleotide Synthesis Market by Application
12.3.1.7.4 Romania Oligonucleotide Synthesis Market by End User
12.3.1.8 Hungary
12.3.1.8.1 Hungary Oligonucleotide Synthesis Market by Product
12.3.1.8.2 Hungary Oligonucleotide Synthesis Market by Type
12.3.1.8.3 Hungary Oligonucleotide Synthesis Market by Application
12.3.1.8.4 Hungary Oligonucleotide Synthesis Market by End User
12.3.1.9 Turkey
12.3.1.9.1 Turkey Oligonucleotide Synthesis Market by Product
12.3.1.9.2 Turkey Oligonucleotide Synthesis Market by Type
12.3.1.9.3 Turkey Oligonucleotide Synthesis Market by Application
12.3.1.9.4 Turkey Oligonucleotide Synthesis Market by End User
12.3.1.10 Rest of Eastern Europe
12.3.1.10.1 Rest of Eastern Europe Oligonucleotide Synthesis Market by Product
12.3.1.10.2 Rest of Eastern Europe Oligonucleotide Synthesis Market by Type
12.3.1.10.3 Rest of Eastern Europe Oligonucleotide Synthesis Market by Application
12.3.1.10.4 Rest of Eastern Europe Oligonucleotide Synthesis Market by End User
12.3.2 Western Europe
12.3.2.1 Western Europe Oligonucleotide Synthesis Market by Country
12.3.2.2 Western Europe Oligonucleotide Synthesis Market by Product
12.3.2.3 Western Europe Oligonucleotide Synthesis Market by Type
12.3.2.4 Western Europe Oligonucleotide Synthesis Market by Application
12.3.2.5 Western Europe Oligonucleotide Synthesis Market by End User
12.3.2.6 Germany
12.3.2.6.1 Germany Oligonucleotide Synthesis Market by Product
12.3.2.6.2 Germany Oligonucleotide Synthesis Market by Type
12.3.2.6.3 Germany Oligonucleotide Synthesis Market by Application
12.3.2.6.4 Germany Oligonucleotide Synthesis Market by End User
12.3.2.7 France
12.3.2.7.1 France Oligonucleotide Synthesis Market by Product
12.3.2.7.2 France Oligonucleotide Synthesis Market by Type
12.3.2.7.3 France Oligonucleotide Synthesis Market by Application
12.3.2.7.4 France Oligonucleotide Synthesis Market by End User
12.3.2.8 UK
12.3.2.8.1 UK Oligonucleotide Synthesis Market by Product
12.3.2.8.2 UK Oligonucleotide Synthesis Market by Type
12.3.2.8.3 UK Oligonucleotide Synthesis Market by Application
12.3.2.8.4 UK Oligonucleotide Synthesis Market by End User
12.3.2.9 Italy
12.3.2.9.1 Italy Oligonucleotide Synthesis Market by Product
12.3.2.9.2 Italy Oligonucleotide Synthesis Market by Type
12.3.2.9.3 Italy Oligonucleotide Synthesis Market by Application
12.3.2.9.4 Italy Oligonucleotide Synthesis Market by End User
12.3.2.10 Spain
12.3.2.10.1 Spain Oligonucleotide Synthesis Market by Product
12.3.2.10.2 Spain Oligonucleotide Synthesis Market by Type
12.3.2.10.3 Spain Oligonucleotide Synthesis Market by Application
12.3.2.10.4 Spain Oligonucleotide Synthesis Market by End User
12.3.2.11 Netherlands
12.3.2.11.1 Netherlands Oligonucleotide Synthesis Market by Product
12.3.2.11.2 Netherlands Oligonucleotide Synthesis Market by Type
12.3.2.11.3 Netherlands Oligonucleotide Synthesis Market by Application
12.3.2.11.4 Netherlands Oligonucleotide Synthesis Market by End User
12.3.2.12 Switzerland
12.3.2.12.1 Switzerland Oligonucleotide Synthesis Market by Product
12.3.2.12.2 Switzerland Oligonucleotide Synthesis Market by Type
12.3.2.12.3 Switzerland Oligonucleotide Synthesis Market by Application
12.3.2.12.4 Switzerland Oligonucleotide Synthesis Market by End User
12.3.2.13 Austria
12.3.2.13.1 Austria Oligonucleotide Synthesis Market by Product
12.3.2.13.2 Austria Oligonucleotide Synthesis Market by Type
12.3.2.13.3 Austria Oligonucleotide Synthesis Market by Application
12.3.2.13.4 Austria Oligonucleotide Synthesis Market by End User
12.3.2.14 Rest of Western Europe
12.3.2.14.1 Rest of Western Europe Oligonucleotide Synthesis Market by Product
12.3.2.14.2 Rest of Western Europe Oligonucleotide Synthesis Market by Type
12.3.2.14.3 Rest of Western Europe Oligonucleotide Synthesis Market by Application
12.3.2.14.4 Rest of Western Europe Oligonucleotide Synthesis Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Oligonucleotide Synthesis Market by Country
12.4.2 Asia Pacific Oligonucleotide Synthesis Market by Product
12.4.3 Asia Pacific Oligonucleotide Synthesis Market by Type
12.4.4 Asia Pacific Oligonucleotide Synthesis Market by Application
12.4.5 Asia Pacific Oligonucleotide Synthesis Market by End User
12.4.6 China
12.4.6.1 China Oligonucleotide Synthesis Market by Product
12.4.6.2 China Oligonucleotide Synthesis Market by Type
12.4.6.3 China Oligonucleotide Synthesis Market by Application
12.4.6.4 China Oligonucleotide Synthesis Market by End User
12.4.7 India
12.4.7.1 India Oligonucleotide Synthesis Market by Product
12.4.7.2 India Oligonucleotide Synthesis Market by Type
12.4.7.3 India Oligonucleotide Synthesis Market by Application
12.4.7.4 India Oligonucleotide Synthesis Market by End User
12.4.8 Japan
12.4.8.1 Japan Oligonucleotide Synthesis Market by Product
12.4.8.2 Japan Oligonucleotide Synthesis Market by Type
12.4.8.3 Japan Oligonucleotide Synthesis Market by Application
12.4.8.4 Japan Oligonucleotide Synthesis Market by End User
12.4.9 South Korea
12.4.9.1 South Korea Oligonucleotide Synthesis Market by Product
12.4.9.2 South Korea Oligonucleotide Synthesis Market by Type
12.4.9.3 South Korea Oligonucleotide Synthesis Market by Application
12.4.9.4 South Korea Oligonucleotide Synthesis Market by End User
12.4.10 Vietnam
12.4.10.1 Vietnam Oligonucleotide Synthesis Market by Product
12.4.10.2 Vietnam Oligonucleotide Synthesis Market by Type
12.4.10.3 Vietnam Oligonucleotide Synthesis Market by Application
12.4.10.4 Vietnam Oligonucleotide Synthesis Market by End User
12.4.11 Singapore
12.4.11.1 Singapore Oligonucleotide Synthesis Market by Product
12.4.11.2 Singapore Oligonucleotide Synthesis Market by Type
12.4.11.3 Singapore Oligonucleotide Synthesis Market by Application
12.4.11.4 Singapore Oligonucleotide Synthesis Market by End User
12.4.12 Australia
12.4.12.1 Australia Oligonucleotide Synthesis Market by Product
12.4.12.2 Australia Oligonucleotide Synthesis Market by Type
12.4.12.3 Australia Oligonucleotide Synthesis Market by Application
12.4.12.4 Australia Oligonucleotide Synthesis Market by End User
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Oligonucleotide Synthesis Market by Product
12.4.13.2 Rest of Asia-Pacific Oligonucleotide Synthesis Market by Type
12.4.13.3 Rest of Asia-Pacific Oligonucleotide Synthesis Market by Application
12.4.13.4 Rest of Asia-Pacific Oligonucleotide Synthesis Market by End User
12.5 Middle East & Africa
12.5.1 Middle East
12.5.1.1 Middle East Oligonucleotide Synthesis Market by country
12.5.1.2 Middle East Oligonucleotide Synthesis Market by Product
12.5.1.3 Middle East Oligonucleotide Synthesis Market by Type
12.5.1.4 Middle East Oligonucleotide Synthesis Market by Application
12.5.1.5 Middle East Oligonucleotide Synthesis Market by End User
12.5.1.6 UAE
12.5.1.6.1 UAE Oligonucleotide Synthesis Market by Product
12.5.1.6.2 UAE Oligonucleotide Synthesis Market by Type
12.5.1.6.3 UAE Oligonucleotide Synthesis Market by Application
12.5.1.6.4 UAE Oligonucleotide Synthesis Market by End User
12.5.1.7 Egypt
12.5.1.7.1 Egypt Oligonucleotide Synthesis Market by Product
12.5.1.7.2 Egypt Oligonucleotide Synthesis Market by Type
12.5.1.7.3 Egypt Oligonucleotide Synthesis Market by Application
12.5.1.7.4 Egypt Oligonucleotide Synthesis Market by End User
12.5.1.8 Saudi Arabia
12.5.1.8.1 Saudi Arabia Oligonucleotide Synthesis Market by Product
12.5.1.8.2 Saudi Arabia Oligonucleotide Synthesis Market by Type
12.5.1.8.3 Saudi Arabia Oligonucleotide Synthesis Market by Application
12.5.1.8.4 Saudi Arabia Oligonucleotide Synthesis Market by End User
12.5.1.9 Qatar
12.5.1.9.1 Qatar Oligonucleotide Synthesis Market by Product
12.5.1.9.2 Qatar Oligonucleotide Synthesis Market by Type
12.5.1.9.3 Qatar Oligonucleotide Synthesis Market by Application
12.5.1.9.4 Qatar Oligonucleotide Synthesis Market by End User
12.5.1.10 Rest of Middle East
12.5.1.10.1 Rest of Middle East Oligonucleotide Synthesis Market by Product
12.5.1.10.2 Rest of Middle East Oligonucleotide Synthesis Market by Type
12.5.1.10.3 Rest of Middle East Oligonucleotide Synthesis Market by Application
12.5.1.10.4 Rest of Middle East Oligonucleotide Synthesis Market by End User
12.5.2. Africa
12.5.2.1 Africa Oligonucleotide Synthesis Market by country
12.5.2.2 Africa Oligonucleotide Synthesis Market by Product
12.5.2.3 Africa Oligonucleotide Synthesis Market by Type
12.5.2.4 Africa Oligonucleotide Synthesis Market by Application
12.5.2.5 Africa Oligonucleotide Synthesis Market by End User
12.5.2.6 Nigeria
12.5.2.6.1 Nigeria Oligonucleotide Synthesis Market by Product
12.5.2.6.2 Nigeria Oligonucleotide Synthesis Market by Type
12.5.2.6.3 Nigeria Oligonucleotide Synthesis Market by Application
12.5.2.6.4 Nigeria Oligonucleotide Synthesis Market by End User
12.5.2.7 South Africa
12.5.2.7.1 South Africa Oligonucleotide Synthesis Market by Product
12.5.2.7.2 South Africa Oligonucleotide Synthesis Market by Type
12.5.2.7.3 South Africa Oligonucleotide Synthesis Market by Application
12.5.2.7.4 South Africa Oligonucleotide Synthesis Market by End User
12.5.2.8 Rest of Africa
12.5.2.8.1 Rest of Africa Oligonucleotide Synthesis Market by Product
12.5.2.8.2 Rest of Africa Oligonucleotide Synthesis Market by Type
12.5.2.8.3 Rest of Africa Oligonucleotide Synthesis Market by Application
12.5.2.8.4 Rest of Africa Oligonucleotide Synthesis Market by End User
12.6. Latin America
12.6.1 Latin America Oligonucleotide Synthesis Market by country
12.6.2 Latin America Oligonucleotide Synthesis Market by Product
12.6.3 Latin America Oligonucleotide Synthesis Market by Type
12.6.4 Latin America Oligonucleotide Synthesis Market by Application
12.6.5 Latin America Oligonucleotide Synthesis Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Oligonucleotide Synthesis Market by Product
12.6.6.2 Brazil Oligonucleotide Synthesis Market by Type
12.6.6.3 Brazil Oligonucleotide Synthesis Market by Application
12.6.6.4 Brazil Oligonucleotide Synthesis Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Oligonucleotide Synthesis Market by Product
12.6.7.2 Argentina Oligonucleotide Synthesis Market by Type
12.6.7.3 Argentina Oligonucleotide Synthesis Market by Application
12.6.7.4 Argentina Oligonucleotide Synthesis Market by End User
12.6.8 Colombia
12.6.8.1 Colombia Oligonucleotide Synthesis Market by Product
12.6.8.2 Colombia Oligonucleotide Synthesis Market by Type
12.6.8.3 Colombia Oligonucleotide Synthesis Market by Application
12.6.8.4 Colombia Oligonucleotide Synthesis Market by End User
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Oligonucleotide Synthesis Market by Product
12.6.9.2 Rest of Latin America Oligonucleotide Synthesis Market by Type
12.6.9.3 Rest of Latin America Oligonucleotide Synthesis Market by Application
12.6.9.4 Rest of Latin America Oligonucleotide Synthesis Market by End User
13. Company Profile
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Company Overview
13.1.2 Financials
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 CPI
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Novartis
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 AstraZeneca
13.4 Company Overview
13.4.2 Financials
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Merck & Co. Inc.
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 GE Healthcare
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Dharmacon Inc.
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Agilent Technologies
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Bio-synthesis
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Kaneka Eurogentec S.A
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Products/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 Integrated DNA Technologies Inc.
13.11.1 Company Overview
13.11.2 Financials
13.11.3 Products/ Services Offered
13.11.4 SWOT Analysis
13.11.5 The SNS View
13.12 BioAutomation
13.12.1 Company Overview
13.12.2 Financials
13.12.3 Products/ Services Offered
13.12.4 SWOT Analysis
13.12.5 The SNS View
13.13 Biolegio
13.13.1 Company Overview
13.13.2 Financials
13.13.3 Products/ Services Offered
13.13.4 SWOT Analysis
13.13.5 The SNS View
13.14 Twist Bioscience
13.14.1 Company Overview
13.14.2 Financials
13.14.3 Products/ Services Offered
13.14.4 SWOT Analysis
13.14.5 The SNS View
13.15 Others
13.15.1 Company Overview
13.15.2 Financials
13.15.3 Products/ Services Offered
13.15.4 SWOT Analysis
13.15.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. USE Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Omega 3 supplements market was valued USD 6.60 billion in 2022 and is estimated to reach USD 12.96 billion by 2030. From 2023 to 2030 & grow at a CAGR of 8.8%.
The Hyperphosphatemia Treatment Market size was valued at USD 2.58 Bn in 2022 and is expected to reach USD 3.84 Bn by 2030 with a CAGR of 5.1% over the forecast period of 2023-2030.
The Upstream Bioprocessing Market size was estimated USD 16.9 billion in 2022 and is expected to reach USD 58.1 billion by 2030 at a CAGR of 16.7% during the forecast period of 2023-2030.
The Healthcare Technology Management Market size was estimated 6.92 USD billion in 2022 and is expected to reach USD 21.34 billion by 2030 at a CAGR of 15.12% during the forecast period of 2023-2030.
In 2023, The Legionella Testing Market size amounted to USD 304.29 billion & is estimated to reach USD 624.35 billion by 2031 and increase at a compound annual growth rate of 9.4% between 2024 and 2031.
The Nanomedicine Market Size was valued at USD 170.47 billion in 2022, and is expected to reach USD 431.21 billion by 2030 and grow at a CAGR of 12.3% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
